Connection

Narendra Vyavahare to Rats

This is a "connection" page, showing publications Narendra Vyavahare has written about Rats.
Connection Strength

1.625
  1. Osteoclast-Mediated Cell Therapy as an Attempt to Treat Elastin Specific Vascular Calcification. Molecules. 2021 Jun 15; 26(12).
    View in: PubMed
    Score: 0.107
  2. Pentagalloyl glucose increases elastin deposition, decreases reactive oxygen species and matrix metalloproteinase activity in pulmonary fibroblasts under inflammatory conditions. Biochem Biophys Res Commun. 2018 04 30; 499(1):24-29.
    View in: PubMed
    Score: 0.085
  3. Reversal of Vascular Calcification and Aneurysms in a Rat Model Using Dual Targeted Therapy with EDTA- and PGG-Loaded Nanoparticles. Theranostics. 2016; 6(11):1975-1987.
    View in: PubMed
    Score: 0.076
  4. A novel crosslinking method for improved tear resistance and biocompatibility of tissue based biomaterials. Biomaterials. 2015 Oct; 66:83-91.
    View in: PubMed
    Score: 0.071
  5. Rat aortic smooth muscle cells cultured on hydroxyapatite differentiate into osteoblast-like cells via BMP-2-SMAD-5 pathway. Calcif Tissue Int. 2015 Apr; 96(4):359-69.
    View in: PubMed
    Score: 0.069
  6. Targeted chelation therapy with EDTA-loaded albumin nanoparticles regresses arterial calcification without causing systemic side effects. J Control Release. 2014 Dec 28; 196:79-86.
    View in: PubMed
    Score: 0.067
  7. Nanoparticle targeting to diseased vasculature for imaging and therapy. Nanomedicine. 2014 Jul; 10(5):1003-12.
    View in: PubMed
    Score: 0.064
  8. Hydroxyapatite and calcified elastin induce osteoblast-like differentiation in rat aortic smooth muscle cells. Exp Cell Res. 2014 Apr 15; 323(1):198-208.
    View in: PubMed
    Score: 0.064
  9. Elasto-regenerative properties of polyphenols. Biochem Biophys Res Commun. 2014 Feb 07; 444(2):205-11.
    View in: PubMed
    Score: 0.064
  10. Efficacy of reversal of aortic calcification by chelating agents. Calcif Tissue Int. 2013 Nov; 93(5):426-35.
    View in: PubMed
    Score: 0.063
  11. High-glucose levels and elastin degradation products accelerate osteogenesis in vascular smooth muscle cells. Diab Vasc Dis Res. 2013 Sep; 10(5):410-9.
    View in: PubMed
    Score: 0.061
  12. Neomycin and carbodiimide crosslinking as an alternative to glutaraldehyde for enhanced durability of bioprosthetic heart valves. J Biomater Appl. 2013 May; 27(8):948-60.
    View in: PubMed
    Score: 0.055
  13. Neomycin fixation followed by ethanol pretreatment leads to reduced buckling and inhibition of calcification in bioprosthetic valves. J Biomed Mater Res B Appl Biomater. 2010 Jan; 92(1):168-77.
    View in: PubMed
    Score: 0.048
  14. Osteogenic responses in fibroblasts activated by elastin degradation products and transforming growth factor-beta1: role of myofibroblasts in vascular calcification. Am J Pathol. 2007 Jul; 171(1):116-23.
    View in: PubMed
    Score: 0.041
  15. Elastin stabilization for treatment of abdominal aortic aneurysms. Circulation. 2007 Apr 03; 115(13):1729-37.
    View in: PubMed
    Score: 0.040
  16. Neomycin prevents enzyme-mediated glycosaminoglycan degradation in bioprosthetic heart valves. Biomaterials. 2007 Jun; 28(18):2861-8.
    View in: PubMed
    Score: 0.040
  17. In vivo cellular repopulation of tubular elastin scaffolds mediated by basic fibroblast growth factor. Biomaterials. 2007 Jun; 28(18):2830-8.
    View in: PubMed
    Score: 0.040
  18. Toward cell therapy for vascular calcification: osteoclast-mediated demineralization of calcified elastin. Cardiovasc Pathol. 2007 Jan-Feb; 16(1):29-37.
    View in: PubMed
    Score: 0.039
  19. Structural requirements for stabilization of vascular elastin by polyphenolic tannins. Biomaterials. 2006 Jul; 27(19):3645-51.
    View in: PubMed
    Score: 0.037
  20. Elastin calcification in the rat subdermal model is accompanied by up-regulation of degradative and osteogenic cellular responses. Am J Pathol. 2006 Feb; 168(2):490-8.
    View in: PubMed
    Score: 0.037
  21. Stability and function of glycosaminoglycans in porcine bioprosthetic heart valves. Biomaterials. 2006 Mar; 27(8):1507-18.
    View in: PubMed
    Score: 0.036
  22. Elastin-derived peptides and TGF-beta1 induce osteogenic responses in smooth muscle cells. Biochem Biophys Res Commun. 2005 Aug 26; 334(2):524-32.
    View in: PubMed
    Score: 0.036
  23. Novel capillary channel fiber scaffolds for guided tissue engineering. Acta Biomater. 2005 Nov; 1(6):607-14.
    View in: PubMed
    Score: 0.036
  24. Biocompatibility and remodeling potential of pure arterial elastin and collagen scaffolds. Biomaterials. 2006 Feb; 27(5):702-13.
    View in: PubMed
    Score: 0.035
  25. Tannic acid treatment enhances biostability and reduces calcification of glutaraldehyde fixed aortic wall. Biomaterials. 2005 Apr; 26(11):1237-45.
    View in: PubMed
    Score: 0.035
  26. Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases. Circulation. 2004 Nov 30; 110(22):3480-7.
    View in: PubMed
    Score: 0.034
  27. Involvement of matrix metalloproteinases and tenascin-C in elastin calcification. Cardiovasc Pathol. 2004 May-Jun; 13(3):146-55.
    View in: PubMed
    Score: 0.033
  28. Role of elastin in pathologic calcification of xenograft heart valves. J Biomed Mater Res A. 2003 Jul 01; 66(1):93-102.
    View in: PubMed
    Score: 0.031
  29. Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration. J Heart Valve Dis. 2003 Mar; 12(2):217-25.
    View in: PubMed
    Score: 0.030
  30. Aluminum chloride pretreatment of elastin inhibits elastolysis by matrix metalloproteinases and leads to inhibition of elastin-oriented calcification. Am J Pathol. 2001 Dec; 159(6):1981-6.
    View in: PubMed
    Score: 0.028
  31. Inhibition of matrix metalloproteinase activity attenuates tenascin-C production and calcification of implanted purified elastin in rats. Am J Pathol. 2000 Sep; 157(3):885-93.
    View in: PubMed
    Score: 0.025
  32. Elastin calcification and its prevention with aluminum chloride pretreatment. Am J Pathol. 1999 Sep; 155(3):973-82.
    View in: PubMed
    Score: 0.024
  33. Prevention of calcification of glutaraldehyde-crosslinked porcine aortic cusps by ethanol preincubation: mechanistic studies of protein structure and water-biomaterial relationships. J Biomed Mater Res. 1998 Jun 15; 40(4):577-85.
    View in: PubMed
    Score: 0.022
  34. Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms. Circulation. 1997 Jan 21; 95(2):479-88.
    View in: PubMed
    Score: 0.020
  35. Nitric oxide stimulates matrix synthesis and deposition by adult human aortic smooth muscle cells within three-dimensional cocultures. Tissue Eng Part A. 2015 Apr; 21(7-8):1455-70.
    View in: PubMed
    Score: 0.017
  36. Inhibition of cusp and aortic wall calcification in ethanol- and aluminum-treated bioprosthetic heart valves in sheep: background, mechanisms, and synergism. J Heart Valve Dis. 2003 Mar; 12(2):209-16; discussion 216.
    View in: PubMed
    Score: 0.008
  37. Prevention of glutaraldehyde-fixed bioprosthetic heart valve calcification by alcohol pretreatment: further mechanistic studies. J Heart Valve Dis. 2000 Jul; 9(4):561-6.
    View in: PubMed
    Score: 0.006
  38. Inhibition of aortic wall calcification in bioprosthetic heart valves by ethanol pretreatment: biochemical and biophysical mechanisms. J Biomed Mater Res. 1998 Oct; 42(1):30-7.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.